AR mutations are identified in >95% of patients with CAIS, 70% of which are maternally inherited mutations; the remaining 30% are de novo mutations (Oakes et al., 2008; Zhang et al., 2021). This evidence concerns the gene AR and complete androgen insensitivity syndrome.